Yu.V. Petrova

Yu.V. Petrova

Auto-generated profile, based on publicly available information

Yu.V. Petrova

Children's City Clinical Hospital No. 9 named after G. N. Speransky, Moscow, Russia

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2024 in Allergology and Immunology in Paediatrics
Verified
Journal Article
Open access
PDF file
LFL. A. Fyodorova
L. A. Fyodorova
YPYu. V. Petrova
Yu. V. Petrova
DLD. M. Levina
D. M. Levina
ИКИ. А. Корсунский
И. А. Корсунский
АКА. А. Корсунский
А. А. Корсунский
DMD. B. Munblit
D. B. Munblit
Relevance. Food allergy (FA) is an important public health concern, particularly among children, with an increasing prevalence. It is associated with a significant decrease in the quality of life for patients and their families due to the need to avoid allergens and the risk of severe allergic reactions, such as anaphylaxis. Despite active research, the primary treatment remains elimination diets, which limit patients’ options and highlight the need for new therapeutic solutions.Aim of the review. This review aims to summarize the current treatment methods for food allergy, discuss the challenges in evaluating the effectiveness of interventions, and highlight the importance of standardizing outcomes in clinical trials to improve comparability and practical relevance.Content. The review discusses modern therapeutic approaches for food allergy, such as oral, epicutaneous, and sublingual immunotherapies, which have shown positive results in achieving tolerance to allergens. Special attention is given to safety concerns, particularly for children, emphasizing the need for further research. The potential use of biological agents, such as omalizumab, in food allergy treatment is also explored. The review addresses challenges in choosing and standardizing endpoints in clinical trials, where most focus on desensitization and immunological markers, while patient-centered outcomes, such as quality of life, remain under-researched. The implementation of “core outcome sets” is highlighted as an important step toward improving data comparability and forming a more objective basis for clinical recommendations.Conclusions. The review emphasizes significant progress in food allergy treatment but notes the need for further research to ensure the safety of new therapies, particularly for children. Standardizing outcomes in clinical trials plays a key role in improving the quality and comparability of research, which will, in turn, help develop more effective clinical guidelines and improve patients’ quality of life.

1 January 2025 in Voprosy detskoj dietologii
Verified
Journal Article
Closed access
KZK.S. Zizyukina
K.S. Zizyukina
HSH.A. Sarkisyan
H.A. Sarkisyan
MDM.I. Dubrovskaya
M.I. Dubrovskaya
MLM.A. Lazareva
M.A. Lazareva
AGA.A. Gryaznova
A.A. Gryaznova
PSP.V. Shumilov
P.V. Shumilov
DiGeorge syndrome, also known as 22q11.2 deletion syndrome (D 82.1, MIM#188400), is one of the most common chromosomal mutations in the human population, associated with abnormalities in the development of the 3rd and 4th pharyngeal pouches and pharyngeal arches, resulting in conotruncal heart defects, hypoparathyroidism and cellular immunodeficiency, which form a triad of major manifestations. Among the 180 clinical signs of DiGeorge syndrome, rare developmental anomalies of the larynx, particularly its congenital membrane, are also described. The laryngeal membrane following by scar stenosis in the anterior third of the vocal cords may cause vomiting due to constant irritation of the laryngeal mechanoreceptors with subsequent reflex stimulation in the vomiting centre. This article presents a clinical case of DiGeorge syndrome in a child with congenital laryngeal membrane complicated by cyclic vomiting syndrome. Despite the absence of congenital heart disease and hypoparathyroidism characteristic of DiGeorge syndrome, the genetic diagnosis of microdeletion on chromosome 22 was established in early childhood. Key words: immunodeficiency, DiGeorge syndrome, chromosome 22 deletion, congenital laryngeal membrane, laryngeal stenosis, vomiting reflex, vomiting syndrome

22 November 2024 in Лечащий врач
Verified
Journal Article
Closed access
DLD.M. Levina
D.M. Levina
SLS.O. Lukyanova
S.O. Lukyanova
NZN.V. Zinovieva
N.V. Zinovieva
JPJ.V. Petrova
J.V. Petrova
MRM.A. Rumyantsev
M.A. Rumyantsev
LFL.A. Fedorova
L.A. Fedorova
Background. Food allergy is a serious, life-threatening condition that negatively impacts the quality of life of patients and their families, especially among children. In Europe, approximately 7 million people suffer from food allergy, while in Russia, the prevalence varies from 5% to 30%. Accurate diagnosis and treatment of food allergy are crucial to preventing complications and improving quality of life. Primary diagnostic methods include medical history, laboratory tests, and elimination diets, though each has its limitations. Globally, oral food challenges are considered the "gold standard" for food allergy diagnosis. It helps to establish a precise connection between the allergen and the reaction, reducing anxiety for patients and their families. Objective. To evaluate the feasibility of using oral food challenges as a diagnostic method for food allergies in children. Materials and methods. This single-center, prospective, interventional, non-randomized, uncontrolled study is being conducted from January 1, 2022, to December 31, 2024, at the G. N. Speransky Children’s Hospital No. 9 in Moscow. Children aged 6 months to 17 years, suspected of having an immediate allergic reaction to cow's milk protein and/or egg protein by a doctor or legal guardian, were invited to participate. The study involves using an open food challenge for diagnosing food allergies. An open food challenge involves consuming increasing amounts of the suspected allergen (milk, egg, etc.) in its natural form under medical supervision. To determine the necessity of a provocation test, a consultation is conducted, including a physical examination, medical history, and allergy testing (specific IgE blood tests, component diagnostics for milk and egg, and a prick test with the native allergen). Additionally, during the consultation, questionnaires on anxiety and quality of life were completed. Our patient selection and test procedure algorithm is an adapted version of existing protocols from international allergology organizations. Conclusions. Preliminary results indicate that the provocation test is a safe diagnostic method when following a strict patient selection and test procedure algorithm. Notably, parents of children undergoing these tests exhibit high anxiety levels. We plan to continue this study and assess personal and situational anxiety levels over time post oral food challenges.

14 June 2024 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
OHOncology And Immunology Named After Dmitry Rogachev National Scientific And Practical Center For Pediatric Hematology
Oncology And Immunology Named After Dmitry Rogachev National Scientific And Practical Center For Pediatric Hematology
AMA.YU. Mishchenko
A.YU. Mishchenko
YPYu.V. Petrova
Yu.V. Petrova
M9Moscow G.N. Speransky City Children’s Hospital No. 9
Moscow G.N. Speransky City Children’s Hospital No. 9
NDN.V. Davydova
N.V. Davydova
NZN.V. Zinovyeva
N.V. Zinovyeva
Article represents a clinical case of severe combined immune deficiency (SCID), deficiency of MHC class II molecules which was coupled with normal levels of TREC and KREC in a pediatric patient. Simultaneous determination of TREC and KREC in dried blood spots during neonatal screening makes it possible to diagnose various forms of congenital immunodeficiency disorders. For example, a dramatic decrease in TREC is observed in most SCIDs and combined immune deficiencies. However, in some SCIDs associated with a defect primarily in T-cell function rather than T-cell differentiation, TREC levels do not exceed established threshold levels and therefore some rare forms of SCIDs may be missed by neonatal screening programs and consequently lead to its late diagnosis.

26 September 2024 in CHILDREN INFECTIONS
Verified
Journal Article
Open access
PDF file
ARA. L. Rossina
A. L. Rossina
SCS. B. Chuelov
S. B. Chuelov
NKN. V. Kondratenko
N. V. Kondratenko
АТА. В. Тебеньков
А. В. Тебеньков
EGE. V. Grushitskaya
E. V. Grushitskaya
OSO. V. Shamsheva
O. V. Shamsheva
Висцеральная (печеночно-селезеночная) форма бартонеллеза